CA Stock MarketDetailed Quotes

IBO Universal Ibogaine Inc

Watchlist
  • 0.010
  • -0.005-33.33%
15min DelayMarket Closed Nov 11 16:00 ET
3.09MMarket Cap-1000P/E (TTM)

Universal Ibogaine Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-191.16%-501.22K
85.84%-68.03K
59.05%-184.43K
74.67%-1.1M
100.34%5.8K
77.50%-172.15K
56.94%-480.6K
39.10%-450.43K
-33.34%-4.33M
-12,954.28%-1.71M
Net income from continuing operations
-77.23%-862.39K
71.97%-222.2K
75.31%-207.85K
77.23%-2.39M
93.13%-269K
58.54%-486.6K
23.75%-792.86K
80.71%-841.96K
-171.41%-10.5M
-4,595.57%-3.92M
Operating gains losses
----
----
----
----
----
----
----
----
-129.43%-875
---791
Depreciation and amortization
11.27%80.46K
17.91%81.86K
26.27%83.76K
11.13%296.05K
11.13%87.97K
1.04%72.32K
0.71%69.43K
41.97%66.33K
281.35%266.4K
104,063.16%79.16K
Asset impairment expenditure
--360K
--0
----
-86.70%360K
-94.46%150K
--0
--210K
----
--2.71M
--2.71M
Remuneration paid in stock
-75.44%6.31K
539.42%11.43K
-91.91%7.9K
-88.30%105.7K
-112.28%-14.98K
-35.87%25.71K
94.48%-2.6K
-87.63%97.58K
--903.54K
--121.95K
Other non cashItems
-65.82%5.92K
-78.33%5.92K
--5.92K
-98.76%34.69K
-995,600.00%-9.96K
--17.32K
--27.33K
----
238.11%2.79M
--1
Change In working capital
-145.97%-91.53K
577.77%54.96K
-132.58%-74.16K
197.81%496.6K
108.79%61.76K
-32.96%199.11K
108.26%8.11K
5,486.11%227.62K
-80.08%-507.7K
-1,100.07%-702.36K
-Change in receivables
----
----
-248.89%-170.39K
5,961.69%155.06K
--59.27K
----
----
--114.44K
103.23%2.56K
----
-Change in prepaid assets
----
----
17.88%23.76K
114.76%5.29K
--52.56K
----
----
--20.16K
91.84%-35.86K
----
-Change in payables and accrued expense
----
----
1.20%94.13K
148.53%230.25K
---17.17K
----
----
--93.02K
-300.13%-474.4K
----
-Change in other working capital
----
----
---21.67K
--106K
---32.9K
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-191.16%-501.22K
85.84%-68.03K
59.05%-184.43K
74.67%-1.1M
100.34%5.8K
77.50%-172.15K
56.94%-480.6K
39.10%-450.43K
-33.34%-4.33M
-12,954.28%-1.71M
Investing cash flow
Cash flow from continuing investing activities
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
82.77%-360.04K
-102.80%-16.99K
49.07%-42.74K
-1,878.04%-210.79K
96.59%-89.52K
-4,766.26%-2.09M
606.25K
Net PPE purchase and sale
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
-329.51%-360.04K
-44.39%-16.99K
49.07%-42.74K
-1,878.04%-210.79K
---89.52K
---83.83K
---11.77K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---2.05M
--618.02K
Net other investing changes
----
----
----
----
----
----
----
----
200.00%42.93K
--0
Cash from discontinued investing activities
Investing cash flow
54.82%-19.31K
95.65%-9.17K
66.00%-30.44K
82.77%-360.04K
-102.80%-16.99K
49.07%-42.74K
-1,878.04%-210.79K
96.59%-89.52K
-4,766.26%-2.09M
--606.25K
Financing cash flow
Cash flow from continuing financing activities
66.53%626.05K
56.75%281.7K
-88.08%61.7K
-85.09%1.04M
76.54%-28.6K
238.29%375.93K
1,734.79%179.71K
-93.02%517.58K
107.14%7.01M
-105.71%-121.89K
Net issuance payments of debt
-108.71%-32.73K
-117.97%-32.3K
-107.55%-38.3K
-14.33%1.03M
76.54%-28.6K
238.29%375.93K
728.52%179.71K
-68.86%507.58K
321.38%1.21M
---121.88K
Net common stock issuance
--992.77K
--317.19K
900.00%100K
-99.84%10K
--0
--0
--0
-99.84%10K
84.29%6.07M
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--17.6K
--0
Net other financing activities
---333.99K
---3.19K
----
----
----
----
----
----
-46.46%-292.72K
-100.00%-1
Cash from discontinued financing activities
Financing cash flow
66.53%626.05K
56.75%281.7K
-88.08%61.7K
-85.09%1.04M
76.54%-28.6K
238.29%375.93K
1,734.79%179.71K
-93.02%517.58K
107.14%7.01M
-105.71%-121.89K
Net cash flow
Beginning cash position
89.89%364.59K
-77.25%160.09K
-56.85%313.26K
410.60%726.05K
-81.93%353.05K
-93.76%192K
-83.21%703.67K
410.60%726.05K
170.43%142.2K
3,647.92%1.95M
Current changes in cash
-34.48%105.52K
139.97%204.5K
-584.62%-153.17K
-170.70%-412.78K
96.76%-39.79K
114.37%161.05K
54.12%-511.67K
-100.55%-22.37K
551.51%583.85K
-157.93%-1.23M
End cash Position
33.16%470.11K
89.89%364.59K
-77.25%160.09K
-56.85%313.26K
-56.85%313.26K
-81.93%353.05K
-93.76%192K
-83.21%703.67K
410.60%726.05K
-66.57%726.05K
Free cash from
-142.23%-520.53K
88.83%-77.21K
60.21%-214.87K
67.09%-1.46M
99.35%-11.19K
74.69%-214.89K
38.06%-691.38K
26.99%-539.95K
-36.28%-4.43M
-13,044.00%-1.72M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Apr 30, 2024 (Q2)Jan 31, 2024 (Q1)Oct 31, 2023 (FY)Jul 31, 2023 (Q4)Jul 31, 2023 (Q3)Apr 30, 2023 (Q2)Jan 31, 2023 (Q1)Oct 31, 2022 (FY)Jul 31, 2022 (Q4)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -191.16%-501.22K 85.84%-68.03K 59.05%-184.43K 74.67%-1.1M 100.34%5.8K 77.50%-172.15K 56.94%-480.6K 39.10%-450.43K -33.34%-4.33M -12,954.28%-1.71M
Net income from continuing operations -77.23%-862.39K 71.97%-222.2K 75.31%-207.85K 77.23%-2.39M 93.13%-269K 58.54%-486.6K 23.75%-792.86K 80.71%-841.96K -171.41%-10.5M -4,595.57%-3.92M
Operating gains losses ---- ---- ---- ---- ---- ---- ---- ---- -129.43%-875 ---791
Depreciation and amortization 11.27%80.46K 17.91%81.86K 26.27%83.76K 11.13%296.05K 11.13%87.97K 1.04%72.32K 0.71%69.43K 41.97%66.33K 281.35%266.4K 104,063.16%79.16K
Asset impairment expenditure --360K --0 ---- -86.70%360K -94.46%150K --0 --210K ---- --2.71M --2.71M
Remuneration paid in stock -75.44%6.31K 539.42%11.43K -91.91%7.9K -88.30%105.7K -112.28%-14.98K -35.87%25.71K 94.48%-2.6K -87.63%97.58K --903.54K --121.95K
Other non cashItems -65.82%5.92K -78.33%5.92K --5.92K -98.76%34.69K -995,600.00%-9.96K --17.32K --27.33K ---- 238.11%2.79M --1
Change In working capital -145.97%-91.53K 577.77%54.96K -132.58%-74.16K 197.81%496.6K 108.79%61.76K -32.96%199.11K 108.26%8.11K 5,486.11%227.62K -80.08%-507.7K -1,100.07%-702.36K
-Change in receivables ---- ---- -248.89%-170.39K 5,961.69%155.06K --59.27K ---- ---- --114.44K 103.23%2.56K ----
-Change in prepaid assets ---- ---- 17.88%23.76K 114.76%5.29K --52.56K ---- ---- --20.16K 91.84%-35.86K ----
-Change in payables and accrued expense ---- ---- 1.20%94.13K 148.53%230.25K ---17.17K ---- ---- --93.02K -300.13%-474.4K ----
-Change in other working capital ---- ---- ---21.67K --106K ---32.9K ---- ---- ---- ---- ----
Cash from discontinued investing activities
Operating cash flow -191.16%-501.22K 85.84%-68.03K 59.05%-184.43K 74.67%-1.1M 100.34%5.8K 77.50%-172.15K 56.94%-480.6K 39.10%-450.43K -33.34%-4.33M -12,954.28%-1.71M
Investing cash flow
Cash flow from continuing investing activities 54.82%-19.31K 95.65%-9.17K 66.00%-30.44K 82.77%-360.04K -102.80%-16.99K 49.07%-42.74K -1,878.04%-210.79K 96.59%-89.52K -4,766.26%-2.09M 606.25K
Net PPE purchase and sale 54.82%-19.31K 95.65%-9.17K 66.00%-30.44K -329.51%-360.04K -44.39%-16.99K 49.07%-42.74K -1,878.04%-210.79K ---89.52K ---83.83K ---11.77K
Net business purchase and sale ---- ---- ---- --0 ---- ---- ---- ---- ---2.05M --618.02K
Net other investing changes ---- ---- ---- ---- ---- ---- ---- ---- 200.00%42.93K --0
Cash from discontinued investing activities
Investing cash flow 54.82%-19.31K 95.65%-9.17K 66.00%-30.44K 82.77%-360.04K -102.80%-16.99K 49.07%-42.74K -1,878.04%-210.79K 96.59%-89.52K -4,766.26%-2.09M --606.25K
Financing cash flow
Cash flow from continuing financing activities 66.53%626.05K 56.75%281.7K -88.08%61.7K -85.09%1.04M 76.54%-28.6K 238.29%375.93K 1,734.79%179.71K -93.02%517.58K 107.14%7.01M -105.71%-121.89K
Net issuance payments of debt -108.71%-32.73K -117.97%-32.3K -107.55%-38.3K -14.33%1.03M 76.54%-28.6K 238.29%375.93K 728.52%179.71K -68.86%507.58K 321.38%1.21M ---121.88K
Net common stock issuance --992.77K --317.19K 900.00%100K -99.84%10K --0 --0 --0 -99.84%10K 84.29%6.07M --0
Proceeds from stock option exercised by employees ---- ---- ---- --0 ---- ---- ---- ---- --17.6K --0
Net other financing activities ---333.99K ---3.19K ---- ---- ---- ---- ---- ---- -46.46%-292.72K -100.00%-1
Cash from discontinued financing activities
Financing cash flow 66.53%626.05K 56.75%281.7K -88.08%61.7K -85.09%1.04M 76.54%-28.6K 238.29%375.93K 1,734.79%179.71K -93.02%517.58K 107.14%7.01M -105.71%-121.89K
Net cash flow
Beginning cash position 89.89%364.59K -77.25%160.09K -56.85%313.26K 410.60%726.05K -81.93%353.05K -93.76%192K -83.21%703.67K 410.60%726.05K 170.43%142.2K 3,647.92%1.95M
Current changes in cash -34.48%105.52K 139.97%204.5K -584.62%-153.17K -170.70%-412.78K 96.76%-39.79K 114.37%161.05K 54.12%-511.67K -100.55%-22.37K 551.51%583.85K -157.93%-1.23M
End cash Position 33.16%470.11K 89.89%364.59K -77.25%160.09K -56.85%313.26K -56.85%313.26K -81.93%353.05K -93.76%192K -83.21%703.67K 410.60%726.05K -66.57%726.05K
Free cash from -142.23%-520.53K 88.83%-77.21K 60.21%-214.87K 67.09%-1.46M 99.35%-11.19K 74.69%-214.89K 38.06%-691.38K 26.99%-539.95K -36.28%-4.43M -13,044.00%-1.72M
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion with Explanatory Notes --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data